Labor drug policy ‘always part of the plan’

3 May 2022 - Anthony Albanese says Labor had decided on the $12.50 cut to medicines on the PBS before ...

Read more →

Most people won’t get a $10-$12 medicine price cut after election

2 May 2022 - The vast majority of Australians will not benefit from the $10-$12.50 price cut to prescription medicines ...

Read more →

What is the HTA review and why is it important for Australia’s health system?

3 May 2022 - Medicines Australia has released its fourth video in its Federal Election series, explaining the upcoming independent ...

Read more →

Cost of some life-saving drugs to be slashed

1 May 2022 - Changes to the PBS could save some Australians as much as $2.5 million per treatment, as others ...

Read more →

More senior Australians to get cheaper health care and medication under $70m Coalition election pitch

2 May 2022 - More self-funded retirees would be able to access cheaper health care and medication under a multi-million-dollar ...

Read more →

COVID-19 oral treatment listed on PBS from 1 May 2022

1 May 2022 - This prescription only oral treatment has been found to be effective in treating mild to moderate ...

Read more →

Schedule of Pharmaceutical Benefits - 1 May 2022

1 May 2022 - The May 2022 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...

Read more →

New Pharmaceutical Benefits Scheme listings to save patients millions

1 May 2022 - Health Minister Greg Hunt has announced a series of new Pharmaceutical Benefits Scheme listings which will save ...

Read more →

Scott Morrison pledges to cut $10 from Pharmaceutical Benefit Scheme scripts

30 April 2022 - A re-elected Morrison government would cut the price of medicines listed on the Pharmaceutical Benefit Scheme ...

Read more →

Agenda update for the May 2022 PBAC intracycle meeting

29 April 2022 - The agenda for the May 2022 PBAC intracycle meeting has been updated. ...

Read more →

Insights from the March 2022 PBAC meeting (part 3)

29 April 2022 - Wegovy was the first discrete medicine to have a stakeholder meeting before its consideration by the ...

Read more →

Insights from the March 2022 PBAC meeting (part 2)

28 April 2022  The rejection of dostarlimab should not come as a surprise, the rejection of sotorsaib less so. ...

Read more →

PBS brings hope to cancer patients

25 April 2022 - Late-stage breast cancer patients, many of them young women, will have access to a life-extending medication ...

Read more →

Insights from the March 2022 PBAC meeting (part 1)

26 April 2022 - Yesterday, we noted a recommendation rate of 78% which the highest value we have recorded since ...

Read more →

Cost of medicines a key election issue

22 April 2022 - Health and community pharmacy peak bodies have formed a coalition urging parties to recognise medicine affordability ...

Read more →